The Invenia ABUS Premium device reportedly offers consistent high-resolution imaging and up to a 40 percent increase in scan speeds for women with dense breasts.
For women with dense breasts, the newly launched Invenia ABUS Premium device offers a combination of artificial intelligence (AI) tools and enhanced 3D ultrasound imaging quality to facilitate detection and characterization of breast lesions.
In addition to automated breast ultrasound (ABUS) technology that aids in the detection of malignancies, the Invenia ABUS Premium device offers AI tools such as Scan Quality Assessment, which helps ensure proper coverage and positioning of breasts for scanning, and Auto Nipple Detection for enabling consistent nipple marker positions, according to GE HealthCare, the developer of the Invenia ABUS Premium platform.
Improved imaging resolution with the recently launched Invenia ABUS Premium system reveals smaller hypoechoic lesions in the above case. (Images courtesy of GE HealthCare.)
The company added that a Fast Scan tool with the Invenia ABUS Premium device provides up a 40 percent increase in scan speed, and a combination of the Invenia ABUS Viewer with AI Assistant allows expeditious review and assessment of ultrasound exams.
“Women with dense breasts often face poorer outcomes due to malignancies detected at later, more advanced stages. Invenia ABUS Premium equipped with AI has the potential to optimize clinicians’ screening capabilities, enabling them to detect even small, early-stage cancers with a high degree of confidence in women with dense breasts,” said Karley Yoder, the CEO of Comprehensive Care Ultrasound at GE HealthCare.
GE HealthCare said another key feature with the Invenia ABUS Premium system is the Reverse Curve tranducer, which offers one to maximize patient comfort with selectable compression levels and enables more precise contouring of breast anatomy.
“The new Reverse Curve transducer makes the examination more patient friendly, and it is much more comfortable. There has been great improvement in image quality with less shadowing, and the structures behind the area of the nipple are seen more clearly, providing radiologists with greater diagnostic confidence,” added Athina Vourtsis, M.D., Ph.D, the chief director and founder of Athena Medical in Athens, Greece, and a member of the medical advisory board for DenseBreast-Info.org .
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.